The tariff-fueled drop in stocks would be relatively mild compared to what the market could see if recession strikes, Goldman ...

BridgeBio's valuation relies on the commercialization of Attruby, but the drug's full potential may be undermined by tafamidis’ patent extension, introduction of generic alternatives, and other ...

U.S. stock index futures pointed to a lower open on Wednesday as data showed the world's largest economy contracted in the ...

The move echoes efforts by the administration to find financial upsides for its foreign-policy moves in places like Ukraine and Gaza, and follows a multiweek bombing campaign by the U.S. aimed at ...

Markets cheered after the inauguration of a president who campaigned on sending America’s economy soaring. Instead, the Trump ...

Baron Real Estate Income Fund declined in the first quarter of 2025, underperforming its benchmark, the MSCI USA IMI Extended ...

U.S. equities declined -4.3% due to increasing caution surrounding AI-levered Magni1cent Seven stocks and concerns ...

Greece’s economic standing among its European peers, dismal during the 2010s, was finally bolstered by upgraded ...

The shift in the global economy’s outlook has been reflected in the investment landscape ... are quality businesses trading below their actual worth. The CI First Asset Morningstar International Value ...

Credit rating agency Morningstar DBRS has flagged significant uncertainty regarding the impact of tariff policies on global sovereign credit ratings. In a newly published report, the agency ...

The changes to our model are immaterial and our fair value estimate of $40 per share for no-moat BHP is reiterated. Shares ...

Kganyago said these shocks presented new risks to both growth and inflation, and have rendered the global economic outlook more difficult to predict. “Today when the world economy is in economic ...